Key facts
| Firm | SKNV |
|---|---|
| FEI / inspection ID | 3012384835 |
| Inspection end date | March 6, 2025 |
| Citation count | 1 |
Citations explained
Observation 1 — There is a failure to thoroughly review any unexplained discrepancy whether or
There is a failure to thoroughly review any unexplained discrepancy whether or not the batch h as been aheady distributed. A. On 09 /18/24 in anticipation of your production batch of Magnesium Sulfate fo r Injection, Lot [_1 ~.L(4) J,BUD 11 / 03 /24, your quality unit reviewed and identified atypical behavior in tlie ai'rferenb al pressure readings in the ISO 7 ante-room. Specifically, your quality unit identified 19 occurrences where differential pressure values were as out of specification on 09/18/24 fr om around 10:18am - 10:43am and 3:45pm - 5:24pm; the readings were below and above the specification of o )l4 ' ,, water, ranging from -0.04 - 0.25. Your quality unit attributed the abenant findings to pre-operation activities and later dete1mined the HEPA motor as a contributor to the failures. Your fnm was unable to provide an investigation, or equivalent documentation, which would include product impact assessment, to capture info1mation on the events with suppo1ting scientific justification. This.
What a Form 483 means
A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.
SKNV’s FDA history
Argus HQ has recorded 1 total FDA action tied to SKNV: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.
Frequently asked questions
- What happens after a Form 483 is issued?
- The firm typically has 15 business days to submit a written response describing planned corrections. FDA reviews that response, and unresolved or serious findings can lead to a Warning Letter, import alert, or other enforcement action, though many 483s are resolved without further FDA action.
- Has SKNV had other FDA inspection citations?
- This is the only FDA action Argus HQ has on file for SKNV so far. Argus ingests new FDA records daily.
- What is the FEI / inspection ID for this Form 483?
- FEI / inspection ID: 3012384835.
- Is a Form 483 the same as a Warning Letter?
- No. A Form 483 lists an FDA investigator’s observations at the close of an inspection; it is not a final agency determination. FDA may or may not follow up with a Warning Letter depending on the firm’s response and the severity of the findings.
See if this 483 escalates to a warning letter — before your auditor asks.
Free weekly briefing tracks every FDA inspection outcome.
Related enforcement actions
Full FDA history for SKNVCompiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). SKNV — FDA Form 483 Inspection, March 6, 2025 (1 Citations). Digital Empire LLC. Retrieved from https://argushq.ai/483/fda-483-sknv-2025-03-06-3012384835
"SKNV — FDA Form 483 Inspection, March 6, 2025 (1 Citations)." Argus HQ Research, Digital Empire LLC, 2025, argushq.ai/483/fda-483-sknv-2025-03-06-3012384835.
Argus HQ Research. "SKNV — FDA Form 483 Inspection, March 6, 2025 (1 Citations)." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/483/fda-483-sknv-2025-03-06-3012384835.
@misc{argushq_argushq_ai_483_fda_483_sknv_2025_03_06_3012384835_2025,
title = {SKNV — FDA Form 483 Inspection, March 6, 2025 (1 Citations)},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/483/fda-483-sknv-2025-03-06-3012384835},
note = {Accessed: July 13, 2026}
}
